Association of Clinical Research Professionals (ACRP) Certified Professional Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Prepare for the ACRP Certified Professional Exam with our comprehensive quiz. Elevate your clinical research skills with targeted flashcards and multiple-choice questions. Enhance your readiness with detailed explanations and insights for improved performance!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

Which of the following is NOT a recommendation that can be made by a Data and Safety Monitoring Board?

Continue the trial
Modify the trial
Stop the trial
Initiate marketing of the drug

The correct answer is: Initiate marketing of the drug

The recommendation to initiate marketing of the drug is not within the purview of a Data and Safety Monitoring Board (DSMB). The primary role of a DSMB is to evaluate the data collected during a clinical trial to ensure the safety and well-being of participants, and to monitor the trial's integrity. Their recommendations typically focus on whether to continue the trial, modify aspects of it for safety or effectiveness reasons, or stop it altogether if significant safety concerns arise. The actions taken by a DSMB are strictly related to the conduct of the trial, not to the commercialization or marketing of the product being studied. Marketing decisions are made after the completion of a trial and are typically in the hands of regulatory authorities and the sponsors of the drug development process. Therefore, initiating marketing is outside the scope of what a DSMB can recommend.